Genesis made a high-profile appearance with its full-spectrum IVD product portfolio and precision diagnostic solutions. The company fully showcased a comprehensive range of self-developed in vitro diagnostic reagents and proprietary solutions covering testing for prevalent clinical diseases. Backed by robust core technologies and premium services, Genesis thoroughly addresses healthcare demands across Southeast Asia, catering to testing requirements of hospitals at all tiers, independent laboratories and primary clinics throughout the region. Its participation yielded outstanding market results and wide industry acclaim.

During the exhibition, the professional team of Genesis gave attendees detailed briefings on the company’s R&D philosophy, technical strengths and clinical application value of its products. On-site operational demonstrations were carried out to illustrate the products’ rapid and highly accurate testing performance.

In addition, customized solutions and supporting case studies were offered to address the unique demands of diverse clients and practical challenges arising from various clinical application scenarios.

Taking this exhibition as an opportunity, Genesis will continue to deepen its presence in the Southeast Asian market, ramp up investment in product R&D and localisation, and collaborate with regional partners. Empowering ASEAN’s healthcare sector with precision diagnostic technologies, the company aims to deliver higher-quality, more accessible in vitro diagnostic services to patients worldwide and jointly build a new ecosystem for the development of Asia’s IVD industry.